MedTrace Logo

Internet-Delivered Psychological Treatment for Cancer Survivors

NCT06046586 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-11-21

No results posted yet for this study

Summary

Negative psychological effects of cancer are common, but cancer survivors are rarely offered structured psychological treatment. Internet-delivered treatments have shown some promise, but specific treatment components have not been empirically evaluated which means that it is not clear which therapies that should be prioritized. In this randomized factorial trial at Karolinska Institutet, Stockholm, Sweden, 400 cancer survivors with psychiatric symptoms are enrolled in variations on a 10-week therapist-guided online psychological treatment intended to address the negative psychological long-term effects of cancer. The aim is to determine the contribution of treatment components to the overall effect.

Conditions

Interventions

BEHAVIORAL

Support and information

Emotional and technical support. Information about the long-term effects of cancer.

BEHAVIORAL

Behavioral activation

Behavioral activation with existential themes and emphasis on values and relationships.

BEHAVIORAL

Systematic exposure with mindfulness training

Systematic exposure with mindfulness training with a focus on anxiety about health and/or death, body image, and cancer-related trauma.

BEHAVIORAL

Promotion of health behaviors

An overview of self-management techniques in terms of physical exercise, dietary advice, and strategies for improved sleep.

Sponsors & Collaborators

Principal Investigators

  • Erland Axelsson, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-10
Primary Completion
2029-12-31
Completion
2031-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06046586 on ClinicalTrials.gov